title: [Mucoviscidosis. Therapeutic strategies and survival].
abstract: The life expectancy of patients with cystic fibrosis (CF) has increased considerably during the last decades due to improved therapy; one third of German CF patients has now grown into adult-hood. The present paper describes the main therapeutic principles: oral antistaphylococcal treatment, therapy of chronic bronchopulmonary infection with Pseudomonas aeruginosa using intravenous, inhaled or--in adults--oral antibiotics, and improved regimens for the treatment of malnutrition. Finally, survival data from different CF centres are presented.
authors.affiliation: Abteilung Kinderheilkunde I, Medizinischen Hochschule Hannover.
authors.forename: G
authors.initials: G
authors.lastname: Steinkamp
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001424:Bacterial Infections / Q000188:drug therapy / Q000401:mortality; D002648:Child; D003131:Combined Modality Therapy; D003550:Cystic Fibrosis / Q000401:mortality / Q000628:therapy*; D005527:Food, Fortified; D006801:Humans; D009751:Nutritional Requirements; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000401:mortality; D015996:Survival Rate
chemical_list: D000900:Anti-Bacterial Agents
vernacular_title: Mukoviszidose. Therapiestrategien und Uberleben.